0000919574-17-004352.txt : 20170515 0000919574-17-004352.hdr.sgml : 20170515 20170515165805 ACCESSION NUMBER: 0000919574-17-004352 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20170515 DATE AS OF CHANGE: 20170515 EFFECTIVENESS DATE: 20170515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sofinnova BioEquities, LP CENTRAL INDEX KEY: 0001706472 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-286773 FILM NUMBER: 17845344 BUSINESS ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 4, SUITE 250 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-681-8482 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD STREET 2: BUILDING 4, SUITE 250 CITY: MENLO PARK STATE: CA ZIP: 94025 D 1 primary_doc.xml X0707 D LIVE 0001706472 Sofinnova BioEquities, LP 3000 SAND HILL ROAD BUILDING 4, SUITE 250 MENLO PARK CA CALIFORNIA 94025 650-681-8482 DELAWARE None None Limited Partnership true 2016 -- Sofinnova BioEquities GP LLC 3000 Sand Hill Road Building 4, Suite 250 Menlo Park CA CALIFORNIA 94025 Executive Officer Promoter General Partner -- Sofinnova Ventures, Inc. 3000 Sand Hill Road Building 4, Suite 250 Menlo Park CA CALIFORNIA 94025 Executive Officer Promoter Investment Manager Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 false 2017-01-03 true true true false 0 Indefinite 10345000 Indefinite false 18 0 true 0 true 0 true The Investment Manager receives customary management fees as provided in the Issuer's offering documents. false Sofinnova BioEquities, LP /s/ Jim Brody Jim Brody Chief Compliance Officer 2017-05-15